Denis Chem Lab (BOM:537536) ROCE % : 22.85% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Denis Chem Lab ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Denis Chem Lab's annualized ROCE % for the quarter that ended in Dec. 2023 was 22.85%.

Denis Chem Lab ROCE % Historical Data

The historical data trend for Denis Chem Lab's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Denis Chem Lab ROCE % Chart

Denis Chem Lab Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

14.29

12.97

6.59

13.58

15.32

Denis Chem Lab Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															13.95	5.41	18.27	20.20	22.85

Denis Chem Lab ROCE % Calculation

Denis Chem Lab's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	112.18	/	( ( (963.882 - 253.054)	+	(994.479 - 240.751) )	/ 2 )
	=	112.18	/	( (710.828	+	753.728)	/ 2 )
	=	112.18	/	732.278
	=	15.32 %

Denis Chem Lab's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	176.372	/	( ( (1107.073 - 335.192)	+	(0 - 0) )	/ 1 )
	=	176.372	/	( ( 771.881	+	0 )	/ 1 )
	=	176.372	/	771.881
	=	22.85 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Denis Chem Lab (BOM:537536) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Denis Chem Lab ROCE % Related Terms

Thank you for viewing the detailed overview of Denis Chem Lab's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Denis Chem Lab (BOM:537536) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Denis Chem Lab Ltd (BOM:537536) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Satellite Road, 401 Abhishree Complex, Opposite OM Tower, Beside Bidiwala Park, Ahmedabad, GJ, IND, 380015

Website

http://www.denischemlab.com

Denis Chem Lab Ltd is a pharmaceutical company involved in the manufacturing of pharmaceutical products. The company offers sterile intravenous injectables for human and veterinary use for different therapeutic areas. Its product portfolio includes antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-pyretic Inj. irrigation solutions and dialysis solutions. The company has only one reportable segment which is Manufacturing, and Sales of Transfusion Solution in Bottles It generates its revenues through the sale of transfusion solution in bottles.

Denis Chem Lab (BOM:537536) Headlines

No Headlines